|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Revenues | |||||
| Product Sales, Net | |||||
| Contract revenue | |||||
| Total Revenues | |||||
| Cost of sales (exclusive of amortization of intangibles) | |||||
| Amortization of intangibles | |||||
| Gross profit | |||||
| Operating Expenses: | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Income (Loss) From Operations | |||||
| Other Income (Expense): | |||||
| Interest income | |||||
| Foreign exchange transaction loss | |||||
| Total other income | |||||
| Net Loss Before Income Taxes | |||||
| Unrealized gain on marketable security | |||||
| Other income | |||||
| Change in contingent consideration | |||||
| Interest expense | |||||
| Total other income (expense) | |||||
| Net Income (Loss) Before Income Taxes | |||||
| Income Tax (benefit) | |||||
| Net Income (Loss) | |||||
| Other Comprehensive Income (Loss): | |||||
| Unrealized (loss) from investments | |||||
| Foreign currency translation gain (loss) | |||||
| Total other comprehensive gain (loss) | |||||
| Total other comprehensive (loss) | |||||
| Comprehensive Income (Loss) | |||||
| Net Income (Loss) Per Common Share – Basic (in Dollars per share) | |||||
| Net Income (Loss) Per Common Share – Diluted (in Dollars per share) | |||||
| Weighted Average Common Shares Outstanding – Basic (in Shares) | |||||
| Weighted Average Common Shares Outstanding – Diluted (in Shares) | |||||
Loading...